載入...
Efficacy, quality of life, and acceptability outcomes of atypical antipsychotic augmentation treatment for treatment-resistant depression: protocol for a systematic review and network meta-analysis
BACKGROUND: Major depressive disorder (MDD) is a debilitating and costly mental disorder. Although commercially available antidepressants have proliferated over the last 20 years, a substantial number of patients either do not respond adequately to these drugs or are unable to tolerate their adverse...
Na minha lista:
| 發表在: | Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4234739/ https://ncbi.nlm.nih.gov/pubmed/25373601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2046-4053-3-133 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|